Follow-On Biologics Guidance Will Follow Public Workshop, FDA Tells Senate

FDA's draft guidance on follow-on biologics will be preceded by a scientific workshop on the topic, Acting Commissioner Lester Crawford told the Senate Judiciary Committee June 23